B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Olmutinib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Olmutinib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

tolebrutinib
2 shared targets
spebrutinib
2 shared targets
rociletinib
2 shared targets
acalabrutinib
2 shared targets
poziotinib
2 shared targets
osimertinib
2 shared targets
zanubrutinib
2 shared targets
apitolisib
2 shared targets
ibrutinib
2 shared targets
asp
2 shared targets
Loading evidence profile...

This evidence profile for Olmutinib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.